Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Yield10 Bioscience, Inc. (YTEN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
6.28-0.12 (-1.87%)
At close: 4:00PM EDT
6.38 +0.10 (+1.59%)
After hours: 05:50PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
MACD

MACD

Previous Close6.40
Open6.36
Bid6.04 x 2200
Ask6.39 x 1800
Day's Range6.09 - 6.46
52 Week Range5.20 - 23.49
Volume64,361
Avg. Volume45,803
Market Cap30.592M
Beta (5Y Monthly)1.16
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for YTEN

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Yield10 Bioscience, Inc.
    Daily Spotlight: Home Prices SoaringThe U.S. housing market has been a positive contributer to the economic recovery from the pandemic, though some of the statistics have fallen from recent highs and we no longer anticipate the sector will be a strong driver of above-trend GDP growth. The National Association of Realtors reported that existing home sales fell 2% in August from July, to a 5.88 million seasonally adjusted annual rate (still well above the 3.9 million rate in May 2020 but down from the 6.7 million rate in October 2020). The Census Bureau reported that new one-family homes were selling at a 740,000/year rate in August -- again, up from the 582,000 rate at the pandemic depths, but down from 993,000 in January 2021. Meanwhile, the story is similar in a leading indicator for the industry, housing permits. While most of these indicators have cooled, housing prices have not. The S&P/Case-Shiller National Home Price Index for July 2021 showed that prices gained 19.7% year-over-year (the highest gain in 15 years). Inventories have risen along with prices. On the other side of the pandemic, we expect that demand for homes -- with yards between neighbors and plenty of space -- will be solid, supporting domestic economic growth. But the strong growth of the past few quarters should cool.
    Rating
    Fair Value
    Economic Moat
    8 days agoArgus Research
View more
  • GlobeNewswire

    Yield10 Bioscience to Participate in Maxim Group AgTech Virtual Conference

    WOBURN, Mass., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, announced today that President and CEO Oliver Peoples, Ph.D. will present at the Maxim Group Global AgTech Conference, which is being held virtually on October 14, 2021. The event will consist of four virtual panels with participation by executive management from multiple companies in the AgTech sector. Dr. Peoples will be presenting on the “Innovative Food Technologies” p

  • GlobeNewswire

    Yield10 Bioscience to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

    WOBURN, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, announced today that President and CEO Oliver Peoples, Ph.D. will give a corporate presentation at the H.C. Wainwright 23rd Annual Global Investment Conference, which is being held virtually from September 13 – 15, 2021. Yield10 management will also be available to participate in one-on-one meetings with investors who are registered to attend the conference. Event: H.C.

  • GlobeNewswire

    Yield10 Bioscience Announces Second Quarter 2021 Financial Results

    Management will Host a Conference Call Today at 4:30 p.m. (ET) to Review Financial Results and Provide a Corporate Update WOBURN, Mass., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today reported financial results for the three and six months ended June 30, 2021. "We are focused on executing against our core business strategy of utilizing Camelina as a platform crop to produce food, fuel, and PHA bioplastic," said Oliver Peoples,

Advertisement
Advertisement